Safety and Efficacy of a Topical Sodium Channel Inhibitor (TV-45070) in Patients With Postherpetic Neuralgia (PHN): A Randomized, Controlled, Proof-of-Concept, Crossover Study, With a Subgroup Analysis of the Nav1.7 R1150W Genotype.
Journal Information
Full Title: Clin J Pain
Abbreviation: Clin J Pain
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Psychophysiology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"This was an industry-sponsored study (Xenon Pharmaceuticals Inc.). Several authors are current or former employees of Xenon Pharmaceuticals Inc. (N.P., R.N., J.N., K.J.W.P., R.P.S., S.N.P., Y.P.G.)."
"This was an industry-sponsored study (Xenon Pharmaceuticals Inc.). Several authors are current or former employees of Xenon Pharmaceuticals Inc. (N.P., R.N., J.N., K.J.W.P., R.P.S., S.N.P., Y.P.G.)."
"A central independent review board approved the study protocol and amendments. All participants provided written informed consent. The study was performed in accordance with the Declaration of Helsinki and International Conference on Harmonization Guideline on Good Clinical Practice and is registered with ClinicalTrials.gov (NCT01195636)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025